Impact of Late Gadolinium Enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 254, Issue , 2018, Pages 230-237

  Ganesan, Anand N ^a,b,c   Gunton, James ^a   Nucifora, Gaetano ^c   McGavigan, Andrew D ^a,b   Selvanayagam, Joseph B ^a,b,c  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cardiovascular magnetic resonance; Late Gadolinium Enhancement; Meta analysis; Systematic review

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORBIDITY; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; CARDIOMYOPATHY; COHORT ANALYSIS; DIAGNOSTIC IMAGING; HEART MUSCLE ISCHEMIA; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRENDS;

CARDIOMYOPATHIES; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; GADOLINIUM; HUMANS; MORTALITY; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85042135679     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.10.094     Document Type: Article

References (37)

1. Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E. Jr., Drazner, M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62 (2013), e147–239.
2. Wellens, H.J.J., Schwartz, P.J., Lindemans, F.W., Buxton, A.E., Goldberger, J.J., Hohnloser, S.H., et al. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur. Heart J. 35 (2014), 1642–1651.
3. Moss, A.J., Zareba, W., Hall, W.J., Klein, H., Wilber, D.J., Cannom, D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346 (2002), 877–883.
4. Goldberger, J.J., Basu, A., Boineau, R., Buxton, A.E., Cain, M.E., Canty, J.M. Jr., et al. Risk stratification for sudden cardiac death: a plan for the future. Circulation 129 (2014), 516–526.
5. Lee, D.C., Goldberger, J.J., CMR for sudden cardiac death risk stratification: are we there yet?. JACC Cardiovasc Imaging 6 (2013), 345–348.
6. Goldberger, J.J., Sudden cardiac death risk stratification in dilated cardiomyopathy: climbing the pyramid of knowledge. Circ. Arrhythm. Electrophysiol. 7 (2014), 1006–1008.
7. Gorgels, A.P., Gijsbers, C., de Vreede-Swagemakers, J., Lousberg, A., Wellens, H.J., Out-of-hospital cardiac arrest—the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur. Heart J. 24 (2003), 1204–1209.
8. Chugh, S.S., Reinier, K., Teodorescu, C., Evanado, A., Kehr, E., Samara, M.A., et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. 51 (2008), 213–228.
9. Narayanan, K., Reinier, K., Uy-Evanado, A., Teodorescu, C., Chugh, H., Marijon, E., et al. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation 128 (2013), 1733–1738.
10. Stecker, E.C., Vickers, C., Waltz, J., Socoteanu, C., John, B.T., Mariani, R., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J. Am. Coll. Cardiol. 47 (2006), 1161–1166.
11. Kober, L., Thune, J.J., Nielsen, J.C., Haarbo, J., Videbaek, L., Korup, E., et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N. Engl. J. Med. 375 (2016), 1221–1230.
12. Moon, J.C.C., Reed, E., Sheppard, M.N., Elkington, A.G., Ho, S., Burke, M., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 43 (2004), 2260–2264.
13. McCrohon, J.A., Moon, J.C., Prasad, S.K., McKenna, W.J., Lorenz, C.H., Coats, A.J., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003), 54–59.
14. Aljaroudi, W.A., Flamm, S.D., Saliba, W., Wilkoff, B.L., Kwon, D., Role of CMR imaging in risk stratification for sudden cardiac death. JACC Cardiovasc. Imaging 6 (2013), 392–406.
15. Zaman, S., Kovoor, P., Sudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary prevention. Circulation 129 (2014), 2426–2435.
16. American College of Cardiology Foundation Task Force on Expert Consensus D, Hundley, W.G., Bluemke, D.A., Finn, J.P., Flamm, S.D., Fogel, M.A., et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 55 (2010), 2614–2662.
17. Schmidt, A., Azevedo, C.F., Cheng, A., Gupta, S.N., Bluemke, D.A., Foo, T.K., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007), 2006–2014.
18. KC, Wu, Weiss, R.G., Thiemann, D.R., Kitagawa, K., Schmidt, A., Dalal, D., et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51 (2008), 2414–2421.
19. Iles, L., Pfluger, H., Lefkovits, L., Butler, M.J., Kistler, P.M., Kaye, D.M., et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J. Am. Coll. Cardiol. 57 (2011), 821–828.
20. Masci, P.G., Doulaptsis, C., Bertella, E., Del Torto, A., Symons, R., Pontone, G., et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ. Heart Fail. 7 (2014), 448–456.
21. Kwong, R.Y., Chan, A.K., Brown, K.A., Chan, C.W., Reynolds, H.G., Tsang, S., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006), 2733–2743.
22. Cheong, B.Y., Muthupillai, R., Wilson, J.M., Sung, A., Huber, S., Amin, S., et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 120 (2009), 2069–2076.
23. Yan, A.T., Shayne, A.J., Brown, K.A., Gupta, S.N., Chan, C.W., Luu, T.M., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006), 32–39.
24. Rahimi, K., Banning, A.P., Cheng, A.S., Pegg, T.J., Karamitsos, T.D., Channon, K.M., et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 95 (2009), 1937–1943.
25. Sackett, D.L., Haynes, R.B., The architecture of diagnostic research. BMJ 324 (2002), 539–541.
26. Selvanayagam, J., Prasad, S.K., McGavigan, A.D., Hillis, G., Jung, W., Krum, H., Cardiovascular Magnetic Resonance GUIDEd management of mild-moderate left ventricular systolic Heart Failure (CMR GUIDE HF): study protocol for a randomised controlled trial. J. Cardiovasc. Magn. Reson. 17 (2015), 1–2.
27. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
28. Disertori, M., Rigoni, M., Pace, N., Casolo, G., Mase, M., Gonzini, L., et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc. Imaging 9 (2016), 1046–1055.
29. Scott, P.A., Rosengarten, J.A., Curzen, N.P., Morgan, J.M., Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur. J. Heart Fail. 15 (2013), 1019–1027.
30. Parmar, M.K., Torri, V., Stewart, L., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med. 17 (1998), 2815–2834.
31. Tierney, J.F., Stewart, L.A., Ghersi, D., Burdett, S., Sydes, M.R., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 2007, 16.
32. Higgins, J., Thompson, S., Deeks, J., Altman, D., Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J. Health Serv. Res. Policy 7 (2002), 51–61.
33. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986), 177–188.
34. Duan, X., Li, J., Zhang, Q., Zeng, Z., Luo, Y., Jiang, J., et al. Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients: a meta-analysis. Clin. Radiol. 70 (2015), 999–1008.
35. Kim, E.K., Chattranukulchai, P., Klem, I., Cardiac magnetic resonance scar imaging for sudden cardiac death risk stratification in patients with non-ischemic cardiomyopathy. Korean J. Radiol. 16 (2015), 683–695.
36. Zemrak, F., Petersen, S.E., Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog. Cardiovasc. Dis. 54 (2011), 215–229.
37. Russo, A.M., Stainback, R.F., Bailey, S.R., Epstein, A.E., Heidenreich, P.A., Jessup, M., et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J. Am. Coll. Cardiol. 61 (2013), 1318–1368.